Ricerca sul cancro
New biomarker improves early lung cancer detection
04 ottobre 2025 Immagine generata dall'IA
Researchers have identified a novel protein biomarker that detects lung cancer at an early stage with high accuracy. The discovery, detailed in a recent study, could enhance screening methods and improve patient outcomes. Clinical trials showed promising results in identifying the disease before symptoms appear.
Bacteria in tumors produce molecule to boost cancer chemotherapy
Scientists have identified a molecule produced by bacteria inside tumors that enhances the effectiveness of chemotherapy against colorectal cancer. The compound, 2-methylisocitrate, damages cancer cell DNA and disrupts their metabolism. This discovery could lead to new treatments that make existing drugs more potent.
Summit's Lung Cancer Drug Shows Promise
Biotech company Summit announced promising results from its lung cancer drug in recent trials. The drug demonstrated potential efficacy in treating advanced cases, marking a step forward in oncology treatments. Further studies are planned to confirm these findings.
Catalogo delle cicatrici del DNA apre vie per superare le resistenze ai farmaci contro il cancro
03 ottobre 2025 Riportato dall'IA
Ricercatori del Centro nazionale di ricerca sul cancro (CNIO) in Spagna hanno sviluppato un catalogo completo di 'cicatrici' mutazionali nel DNA causate dal cancro. Questa svolta, pubblicata su Nature, potrebbe aiutare a superare le resistenze ai trattamenti come gli inibitori di PARP. Lo studio analizza migliaia di campioni tumorali per identificare schemi genetici chiave.
Researchers develop new method for early cancer detection
30 settembre 2025 Riportato dall'IA
Scientists at the University of Cambridge have unveiled a groundbreaking blood test that detects cancer earlier than existing methods. The technique analyzes circulating tumor DNA with high accuracy. This innovation could revolutionize screening and treatment worldwide.